21 research outputs found
Effects of lipid-lowering drugs on adiponectin
Adiponectin has been implicated in the pathogenesis of coronary heart disease. We review the literature describing the effect of lipid-lowering agents on adiponectin bioavailability. Statins exert variable effects that can be influenced by patient-dependent characteristics (i.e. diabetes or insulin resistance). Fibrates and especially niacin can raise adiponectin levels. The impact of plant sterols, ezetimibe and ω-3 fish oils on adiponectin in humans remains to be defined. There was no literature on whether resins can alter adiponectin levels. As far as mechanisms are concerned, statins enhance peroxisome proliferator-activator receptor (PPAR)-γ activation and have antioxidant or anti-inflammatory potential. Niacin, ω-3 fatty acids, plant sterols and bezafibrate primarily act by increasing PPAR-γ activity and possibly by reducing oxidative stress or inflammation. Both fibrates and ω-3 fish oils act as synthetic ligands for PPAR-α. Hypolipidaemic drugs can affect adiponectin bioavailability, although the impact depends on the individual drug administered and patient characteristics. However, with the exception of niacin, the results observed are not conclusive. © 2010 Bentham Science Publishers Ltd
Sonographic assessment of regional adiposity
OBJECTIVE. Various noninvasive imaging techniques, including CT, MRI, and sonography, have been used for accurate estimation of regional fat deposits. Among these techniques, sonography has attracted considerable attention because it combines safety, cost-effectiveness, and accuracy. The aim of this review is to present an overview of the studies in which sonographic techniques have been used to estimate visceral adiposity, the indexes derived, and the correlation between the indexes and metabolic and cardiovascular markers. CONCLUSION. It is highly plausible that sonography will be used in clinical practice for the routine assessment of regional adiposity. © American Roentgen Ray Society
The HIV-1/HAART associated metabolic syndrome - Novel adipokines, molecular associations and therapeutic implications
The use of highly active anti-retroviral therapy has been associated
with effects on various metabolic and morphological parameters that are
underlied by significant hormonal and cytokine changes. Novel adipokines
may have a role in the pathogenesis of these changes. In fact, leptin
deficiency and hypoadiponectinemia correlate with lipoatrophy and
central fat accumulation respectively whereas hypoadiponectinemia also
appears to be associated with insulin resistance and lipid disorders.
Preliminary evidence from proof-of-concept studies suggests that
administration of recombinant leptin in replacement doses and/or
administration of medications that increase adiponectin levels may
improve the HIV-1/HAART associated metabolic syndrome (HAMS). Immune
effects of hypoleptinemia and hypoadiponectinemia might have a role in
the evolution of the HAMS that need to be further elucidated. The role
for resistin in relation to HAMS is controversial and further
investigation is necessary. A potential role of other novel cytokines
like visfatin, retinol-binding protein-4, apelin, acylation stimulating
protein, omentin and vaspin needs to be further elucidated. (C) 2010 The
British Infection Society. Published by Elsevier Ltd. All rights
reserved
Giant sternal metastasis secondary to follicular carcinoma of the thyroid gland: Report of a case
A 70-year-old woman was admitted to our department for investigation and treatment of a progressively enlarging multinodular goiter and a fast growing mass infiltrating the sternum. The patient was euthyroid, but computed tomography (CT) and ultrasonography showed a mass in the anterior mediastinum infiltrating the sternum, with a dominant nodule in the right lobe of the thyroid. Fine needle aspiration biopsy results from both the cervical and the mediastinal masses were suggestive of follicular thyroid carcinoma. The patient underwent total thyroidectomy, thymectomy, and total removal of the mass, along with parts of the sternum, sternocleidomastoid muscle, and attached ribs. The thoracic wall was reconstructed with gortex dual mesh covered by muscle flaps from both pectoralis major muscles. Pathological analysis of both masses confirmed the fine needle aspiration findings and the patient received three cycles of radioactive iodine treatment. She had an uneventful postoperative course, but died of a stroke 8 years later. © Springer 2012
Immunohistochemical determination of the extracellular matrix modulation in a rat model of choline-deprived myocardium: The effects of carnitine
Choline has been identified as an essential nutrient with crucial role in many vital biological functions. Recent studies have demonstrated that heart dysfunction can develop in the setting of choline deprivation even in the absence of underlying heart disease. Matrix metalloproteinases (MMPs) are responsible for extracellular matrix degradation, and the dysregulation of MMP-2 and MMP-9 has been involved in the pathogenesis of various cardiovascular disorders. The aim of the study was to investigate the role of MMPs and their inhibitors (TIMPs), in the pathogenesis of choline deficiency-induced cardiomyopathy, and the way they are affected by carnitine supplementation. Male Wistar Albino adult rats were divided into four groups and received standard or choline-deficient diet with or without L-carnitine in drinking water (0.15% w/v) for 1 month. Heart tissue immunohistochemistry for MMP-2, MMP-9, TIMP-1, and TIMP-2 was performed. Choline deficiency was associated with suppressed immunohistochemical expression of MMP-2 and an increased expression of TIMP-2 compared to control, while it had no impact on TIMP-1. MMP-9 expression was decreased without, however, reaching statistical significance. Carnitine did not affect MMP-2, MMP-9, TIMP-1 or TIMP-2 expression. The pattern of TIMP and MMP modulation observed in a choline deficiency setting appears to promote fibrosis. Carnitine, although shown to suppress fibrosis, does not seem to affect MMP-2, MMP-9, TIMP-1 or TIMP-2 expression. Further studies will be required to identify the mechanism underlying the beneficial effects of carnitine. © 2016 Société Française de Pharmacologie et de Thérapeutique
Serum adiponectin and resistin in rats under three isocaloric diets: The effect of sibutramine
The aim of the study was to investigate the effects of (1) macronutrients on food intake, body composition and serum resistin and adiponectin and (2) sibutramine(S) on the above parameters in rats fed with isocaloric diets. Three groups of male Wistar rats (n = 63) were fed with high fat diet (HFD), high carbohydrate diet (HCD) or high protein diet (HPD) for 13 weeks. In the last 3 weeks each group was divided into three subgroups and received S 5 mg/kg or 10 mg/kg, or vehicle. Body weight was measured weekly, gastrocnemius muscle, perirenal, retroperitoneal and epididymal fat were isolated, fat/lean ratio was calculated and serum adiponectin and resistin were assayed. S did not affect lean body mass in any group. HFD was associated with elevated fat/lean ratio regardless of S administration. S at 10 mg/Kg decreased fat/lean ratio in the HCD and HPD and adiponectin in the HFD group. S did not affect resistin in any group. Adiponectin was paradoxically elevated in the HFDS10 compared to the HCD or HPD S10 groups. Resistin was lower in the HCD compared to the HPD and HFD groups. Results suggest a preferential effect of S on body fat. The detrimental effect of S on adiponectin can be attributed to its sympathomimetic properties. Adiponectin was paradoxically elevated in the HFD and resistin in the HPD group, results that require further investigation. © 2009 Elsevier Ltd. All rights reserved
Effect of sibutramine on regional fat pads and leptin levels in rats fed with three isocaloric diets
Aim. The aim of the study was to investigate: a) the differential effect of the three main macronu- trients on food intake, fat depots and serum leptin levels and b) the impact of sibutramine on the above parameters in rats fed ad libitum with three isocaloric diets. Methods. Three groups of male Wistar rats (n = 63) were fed with a high fat diet (HFD), a high carbohydrate diet (HCD) or a high protein diet (HPD) for 13 weeks. In the last three weeks, each group was divided into three subgroups and received sibutramine (S) either at 5 mg/kg or 10 mg/kg, or vehicle. Food intake was measured daily during the last week of the experiment; perirenal and epididymal fat and fat/lean ratio were calculated and serum leptin was assayed. Results. HFD-fed rats demonstrated elevated food intake and higher regional fat depots. S at 10 mg/kg decreased food intake in the HFD and epididymal fat in the HCD group. S also reduced perirenal fat in the HCD and HPD groups. Leptin levels were higher in rats fed with either the HFD or the HPD compared to those fed with the HCD. Moreover, S at 10 mg/kg decreased serum leptin levels in the HPD group. Conclusions. Results suggest a preferential effect of S on perirenal visceral fat and support the view that body fat loss is greater when its administration is accompanied by a HCD diet. No effect of S on leptin levels was found, besides that expected as a result of the decrease in body fat
Should Diaphragmatic Involvement Preclude Resection of Large Hepatic Tumors?
Treatment of peripherally located liver tumors with diaphragmatic
invasion is technically demanding but does not preclude resection for
cure. The aim of the present study was to compare patients undergoing
combined liver and diaphragmatic resection with those submitted to
hepatectomy alone so as to evaluate the safety, effectiveness, and value
of this complex surgical procedure.
From January 2000 to September 2011, 36 consecutive patients underwent
en bloc liver-diaphragm resection (group A). These were individually
matched for age, gender, tumor size, pathology, and co-morbitidies with
36 patients who underwent hepatectomy alone during the same time (group
B). Operative time, warm ischemia time, blood loss, required
transfusions, postoperative complications, and long-term survival were
evaluated.
Mean operative time was significantly longer in group A than in group B
(165 vs 142 min; P = 0.004). The two groups were comparable regarding
warm ischemia time, intraoperative blood loss, required transfusions,
and postoperative laboratory value fluctuations. Some 33 % of group A
patients developed complications postoperatively as opposed to 23 % of
group B patients (P = 0.03). The mortality rate was 2.8 % in group A
compared to 0 % in group B. Postoperative follow-up demonstrated 60 %
1-year survival for group A patients as opposed to 80 % 1-year survival
for group B patients, a difference that is practically eliminated the
longer the follow-up period is extended (35 vs 40 % 3-year survival and
33 vs 37 % 5-year survival for group A and group B patients,
respectively).
En bloc diaphragmatic and liver resection is a challenging but safe
surgical procedure that is fully justified when diaphragmatic
infiltration cannot be ruled out and the patient is considered fit
enough to undergo surgery